Our Recommendations
- Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
New Publications
- Tests rapides de détection antigéniques pour le diagnostic de mpox (2024)
- Statement on Antigen Rapid Tests for Mpox Diagnosis, 30 October 2024 (2024)
- Mpox Outbreak in Uganda Situation Update 31 July 2025 (2025)
- Plan d’action régional pour la vaccination dans les Amériques 2030 (2025)
- Plan de acción regional sobre inmunización para las Américas 2030 (2025)
Filter
537
Featured
Recommendations
99
New Publications
118
Language
Document type
No document type
220
Guidelines
160
Studies & Reports
30
Manuals
29
Strategic & Response Plan
24
Fact sheets
21
Training Material
14
Online Courses
14
Resource Platforms
10
Infographics
8
Situation Updates
4
Videos
2
App
1
Countries / Regions
Global
28
Latin America and the Carribbean
14
Ukraine
8
Africa
8
India
7
Russia
6
Congo, Democratic Republic of
5
Middle East and North Africa
5
Western and Central Europe
5
Brazil
5
Mozambique
4
South–East Asia Region
4
Haiti
3
Germany
3
West and Central Africa
3
East and Southern Africa
3
South Africa
3
Eastern Europe
3
Yemen
3
Kenya
2
Nigeria
2
Zimbabwe
2
Bangladesh
2
Zambia
2
Pakistan
2
Nepal
1
Colombia
1
Sierra Leone
1
Chile
1
Syria
1
Senegal
1
Afghanistan
1
Guinea
1
Asia
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Argentina
1
Sri Lanka
1
Angola
1
Bhutan
1
Somalia
1
Liberia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Toolboxes
Rapid Response
105
TB
84
HIV
55
Malaria
23
Cholera
22
Refugee
19
COVID-19
13
Caregiver
13
Polio
7
Mental Health
6
Ebola & Marburg
6
Conflict
6
Natural Hazards
5
2.0 Rapid Response
5
Planetary Health
2
NTDs
2
AMR
2
Pharmacy
1
Health Financing Toolbox
1
Zika
1
Prise en charge d’une épidémie de choléra
recommended
Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire, auxiliaires de santé, techniciens sanitaires et logisticiens.
Le document est un guide complet pour la gestion des épidémies de choléra, fournissant des protocoles détaillés pour la prévention, l’investigat...
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Management of a cholera epidemic
recommended
Practical guide for doctors, nurses,laboratory technicians, medical auxiliaries,water and sanitation specialists and logisticians.
The document is a comprehensive guide for managing cholera epidemics, providing detailed protocols for prevention, outbreak investigation, treatment, and control mea...
Translated and adapted from the original English Antiretroviral drugs chart by the East Europe and Central Asia Union of People Living with HIV (ECUO). This resource shows drugs currently available in the Eastern Europe and Central Asia area.
Last update Oct. 2018
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Guide pour les pays à faibles revenus.
What health professionals need to know. The Online learning course is for nurses, doctors and lay HIV counsellors. It covers the diagnosis of HIV infection, management with and without ARV, opportunistic infections and end-of-life care.
What health professionals need to know.
An online learning programme
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
